Alvotech
ALVO • NASDAQ
Alvotech is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Lisa Graver, with a market cap of $1.1B.
Market Cap$1.1B
Employees999.0
CEOLisa Graver
CountryIceland
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Alvotech FAQ
Common questions about Alvotech
Alvotech is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $139.0M.
Alvotech has approximately 999 employees.